-+ 0.00%
-+ 0.00%
-+ 0.00%

Biovica Lands Laboratory Services Deal with US Cancer Center

MT Newswires·08/06/2026 06:03:13
Listen to the news
06:03 AM EDT, 08/06/2026 (MT Newswires) -- Biovica International (BIOVIC-B.ST) secured a laboratory services agreement with an undisclosed cancer center in the US for its blood-based biomarker test DiviTum TKa. The deal establishes the framework for the facility to access DiviTum TKa testing services through the Swedish biotechnology company's laboratory in San Diego, US, according to a Thursday release. DiviTum TKa is used to help monitor disease progression in hormone receptor-positive metastatic breast cancer.